Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia

Clofarabine (40 mg/m(2)/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2 g/m(2)/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (N = 4) and relapsed (N = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myelosuppres...

Descripción completa

Detalles Bibliográficos
Autores principales: Tse, Eric, Leung, Anskar Y. H., Sim, Joycelyn, Lee, Harold K. K., Liu, Herman S. Y., Yip, Sze-Fai, Kwong, Yok-Lam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187852/
https://www.ncbi.nlm.nih.gov/pubmed/21455604
http://dx.doi.org/10.1007/s00277-011-1223-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187852/
https://www.ncbi.nlm.nih.gov/pubmed/21455604
http://dx.doi.org/10.1007/s00277-011-1223-2

Ejemplares similares